ROTIMI WILLIAMS: Open Payments
NPI 1518673953 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 37 payments from 10 companies in 2025. Trend: 2023 $569 · 2024 $1,322 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 11 | $198 |
| Otsuka America Pharmaceutical, Inc. | 6 | $171 |
| Axsome Therapeutics, Inc. | 2 | $136 |
| Alkermes, Inc. | 5 | $108 |
| Janssen Pharmaceuticals, Inc | 3 | $70 |
| ABBVIE INC. | 3 | $65 |
| E.R. Squibb & Sons, L.L.C. | 2 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
Products named: INGREZZA, Auvelity, ABILIFY MAINTENA, SPRAVATO, VRAYLAR, LYBALVI, REXULTI, ARISTADA.
Industry payments across PA — which companies pay providers there.
